MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pacira BioSciences

< Previous 1 2 3 4 5 Next >
News headline image
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
From Pacira BioSciences
Via GlobeNewswire
Tickers CYTH PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Second Quarter 2024 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Appoints Frank D. Lee as Chief Executive Officer
From Pacira BioSciences
Via GlobeNewswire
Tickers BOLT PCRX
News headline image
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Third Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story